Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,253
Closed -$121K 373
2022
Q3
$121K Hold
1,253
0.01% 199
2022
Q2
$132K Buy
1,253
+88
+8% +$11.2K 0.01% 209
2022
Q1
$201K Sell
1,165
-320
-22% -$47.8K 0.02% 183
2021
Q4
$240K Buy
+1,485
New +$239K 0.02% 181
2021
Q3
Sell
-943
Closed -$231K 188
2021
Q2
$231K Buy
+943
New +$247K 0.02% 186

Other funds holding AMED

Valley Wealth Managers's AMED Position: Q4 2022 in Review

Valley Wealth Managers sold out of Amedisys (AMED) in Q4 2022, closing a stake of 1,253 shares — an estimated $121K sold.

Valley Wealth Managers first reported a position in AMED in Q2 2021 and held it in 5 quarters. The position peaked at $240K in Q4 2021. 277 funds tracked by Wall St. Rank hold AMED as of Q4 2022.

  • Valley Wealth Managers reported no remaining Amedisys position as of Q4 2022 after selling out during the quarter.
  • Valley Wealth Managers sold 1,253 Amedisys shares in Q4 2022, an estimated $121K.
  • Valley Wealth Managers first reported a position in Amedisys in Q2 2021 and held it in 5 quarters.
  • Valley Wealth Managers's Amedisys position peaked at $240K in Q4 2021.
  • 277 funds tracked by Wall St. Rank held Amedisys as of Q4 2022.

Based on Valley Wealth Managers's 13F filing for Q4 2022, filed 1 Feb 2023.